Berberine attenuates cigarette smoke-induced acute lung inflammation

Inflammation

Volumn 36, Issue 5, 2013, Pages 1079-1086

  Lin, Kexiong ^a   Liu, Shuanglin ^a   Shen, Yibo ^a   Li, Qi ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

acute lung injury; berberine (Ber); cigarette smoke (CS); inflammation; nuclear factor kappa B (NF B)

Indexed keywords

BERBERINE; CIGARETTE SMOKE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL COUNT; CELL INFILTRATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE RELEASE; DNA BINDING; GEL MOBILITY SHIFT ASSAY; HISTOPATHOLOGY; INFLAMMATORY CELL; LEUKOCYTE COUNT; LUNG INJURY; LUNG INTERSTITIUM; LUNG LAVAGE; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; WESTERN BLOTTING;

MUS; ZIZIPHUS MAURITIANA;

ACUTE LUNG INJURY; ANIMALS; ANTI-INFLAMMATORY AGENTS; BERBERINE; BRONCHOALVEOLAR LAVAGE FLUID; CHEMOKINE CCL2; CHEMOKINE CXCL2; INTERLEUKIN-6; LUNG; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PEROXIDASE; PNEUMONIA; PULMONARY ALVEOLI; PULMONARY EDEMA; SMOKE; SMOKING; TOBACCO; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885189699     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9640-0     Document Type: Article

References (24)

1. Rabe, K.F., B. Beghé, F. Luppi, and L.M. Fabbri. 2007. Update in chronic obstructive pulmonary disease 2006. American Journal of Respiratory and Critical Care Medicine 175: 1222-1232.
2. Rabe, K.F., S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. van Weel, J. Zielinski, and Global Initiative for Chronic Obstructive Lung Disease. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 176: 532-555.
3. Stampfli, M.R., and G.P. Anderson. 2009. How cigarette smoke skews immune responses to promote infection, lung disease and cancer. Nature Reviews Immunology 9: 377-384.
4. Hogg, J.C., F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, L. Buzatu, R.M. Cherniack, R.M. Rogers, F.C. Sciurba, H.O. Coxson, and P.D. Paré. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. The New England Journal of Medicine 350: 2645-2653.
5. Profita, M., A. Sala, A. Bonanno, L. Riccobono, M. Ferraro, S. La Grutta, G.D. Albano, A.M. Montalbano, and M. Gjomarkaj. 2010. Chronic obstructive pulmonary disease and neutrophil infiltration: role of cigarette smoke and cyclooxygenase products. American Journal of Physiology. Lung Cellular and Molecular Physiology 298: L261-L269.
6. Thatcher, T.H., S.B. Maggirwar, C.J. Baglole, H.F. Lakatos, T.A. Gasiewicz, R.P. Phipps, and P.J. Sime. 2007. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. American Journal of Pathology 170: 855-864.
7. Wright, J.G., and J.W. Christman. 2003. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. American Journal of Respiratory Medicine 2: 211-219.
8. Rajendrasozhan, S., J.W. Hwang, H. Yao, N. Kishore, and I. Rahman. 2010. Anti-inflammatory effect of a selective IkappaB kinase-beta inhibitor in rat lung in response to LPS and cigarette smoke. Pulmonary Pharmacology & Therapeutics 23: 172-181.
9. Park, J.J., S.M. Seo, E.J. Kim, Y.J. Lee, Y.G. Ko, J. Ha, and M. Lee. 2012. Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling. Biochemical and Biophysical Research Communications 426: 461-467.
10. Iizuka, N., K. Miyamoto, K. Okita, A. Tangoku, H. Hayashi, S. Yosino, T. Abe, T. Morioka, S. Hazama, and M. Oka. 2000. Inhibitory effect of Coptidis Rhizoma and berberine on the proliferation of human esophageal cancer cell lines. Cancer Letters 148: 19-25.
11. Marinova, E.K., D.B. Nikolova, D.N. Popova, G.B. Gallacher, and N.D. Ivanovska. 2000. Suppression of experimental autoimmune tubulointerstitial nephritis in BALB/c mice by berberine. Immunopharmacology 48: 9-16.
12. Liu, Y., H. Yu, C. Zhang, Y. Cheng, L. Hu, X. Meng, and Y. Zhao. 2008. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. European Journal of Cancer 44: 2425-2432.
13. Zhang, H.Q., H.D. Wang, D.X. Lu, R.B. Qi, Y.P. Wang, Y.X. Yan, and Y.M. Fu. 2008. Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice. Shock 29: 617-622.
14. Vlahos, R., S. Bozinovski, J.E. Jones, J. Powell, J. Gras, A. Lilja, M.J. Hansen, R.C. Gualano, L. Irving, and G.P. Anderson. 2006. Differential protease, innate immunity, and NF-kappaB induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 290: L931-L945.
15. Yao, H., I. Edirisinghe, S.R. Yang, S. Rajendrasozhan, A. Kode, S. Caito, D. Adenuga, and I. Rahman. 2008. Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice. American Journal of Pathology 172: 1222-1237.
16. Tian, J., X. Lin, R. Guan, and J.G. Xu. 2004. The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesthesia and Analgesia 98: 768-774.
17. Li, F., H.D. Wang, D.X. Lu, Y.P. Wang, R.B. Qi, Y.M. Fu, and C.J. Li. 2006. Neutral sulfate berberine modulates cytokine secretion and increases survival in endotoxemic mice. Acta Pharmacologica Sinica 27: 1199-1205.
18. Anto, R.J., A. Mukhopadhyay, S. Shishodia, C.G. Gairola, and B.B. Aggarwal. 2002. Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis 23: 1511-1518.
19. Shishodia, S., P. Potdar, C.G. Gairola, and B.B. Aggarwal. 2003. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24: 1269-1279.
20. Milner, D. 2004. The physiological effects of smoking on the respiratory system. Nursing Times 100: 56-59.
21. Blake, D.J., A. Singh, P. Kombairaju, D. Malhotra, T.J. Mariani, R.M. Tuder, E. Gabrielson, and S. Biswal. 2010. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. American Journal of Respiratory Cell and Molecular Biology 42: 524-536.
22. Podowski, M., C. Calvi, S. Metzger, K. Misono, H. Poonyagariyagorn, A. Lopez-Mercado, T. Ku, T. Lauer, S. McGrath-Morrow, A. Berger, C. Cheadle, R. Tuder, H.C. Dietz, W. Mitzner, R. Wise, and E. Neptune. 2012. Angiotensin receptor blockade attenuates cigarette smoke-induced lung injury and rescues lung architecture in mice. The Journal of Clinical Investigation 122: 229-240.
23. Iribarren, C., D.R. Jacobs Jr., S. Sidney, M.D. Gross, and M.D. Eisner. 2000. Cigarette smoking, alcohol consumption, and risk of ARDS: a 15-year cohort study in a managed care setting. Chest 117: 163-68.
24. Rajendrasozhan, S., S.R. Yang, I. Edirisinghe, H. Yao, D. Adenuga, and I. Rahman. 2008. Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD. Antioxidants & Redox Signaling 10: 799-811.